This cluster is too small to warrant a bearish read-through. Monitor for any C-suite open-market sales exceeding 0.1% of market cap, which would be a more meaningful signal. The next catalyst to watch is the upcoming quarterly earnings release for pipeline and revenue updates.
Price Chart
Executive Summary
Two insiders at Arcutis Biotherapeutics sold a combined $170K in open-market sales over a week. Director Welgus Howard G. also exercised multiple derivative tranches for a net cash outlay of ~$32K, then sold the resulting shares at market prices. The total dollar value is only ~0.005% of ARQT's $3.2B market cap, making this a trivial cluster by proportionality standards. The sales are likely liquidity-driven following option exercises, not a bearish signal on the company's fundamentals.
Key Financial Metrics
Key Facts
- Two insiders sold a total of $170K in open-market sales over 7 days.
- Director Welgus Howard G. exercised 8,192 derivative shares (cash outlay ~$32K) and sold 4,730 shares at $26.18 for $124K.
- Total sales represent ~0.005% of ARQT's $3.2B market cap — immaterial by academic proportionality thresholds.
- No C-suite executives participated in the selling; the cluster is limited to a director and a 'See Remarks' officer.
- The derivative exercises and subsequent sales suggest liquidity/vesting-driven activity, not informed selling.
Financial Impact
Total insider sales of $170K, or ~0.005% of market cap — negligible economic impact.
Risk Factors
- Insider sales could accelerate if the stock continues to appreciate, but current levels are routine.
- No material risk identified from this cluster alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ARQT-1787379288945 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 24, 2026 5w ago | Insider Cluster | $24.86 $26.38 | ▲ +6.11% | ▲ +5.87% | $25.16 (+1.21%) |
Aug 21, 2026 6w ago | Insider Cluster | $25.08 $25.96 | ▲ +3.51% | ▲ +4.04% | $25.16 (+0.32%) |
Aug 19, 2026 6w ago | Insider Cluster | $25.35 $25.38 | ▲ +0.12% | ▲ +0.12% | $25.16 (−0.75%) |
Aug 11, 2026 7w ago | 144 | $26.28 $23.38 | ▼ −11.04% | ▼ −9.14% | $25.16 (−4.26%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 5, 2026 8w ago | Press Release | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 3, 2026 8w ago | 144 | $26.03 $23.75 | ▼ −8.76% | ▼ −7.52% | $25.16 (−3.34%) |
Jun 29, 2026 13w ago | Press Release | $26.22 $27.84 | ▲ +6.18% | ▲ +7.21% | $25.16 (−4.04%) |
Jun 18, 2026 15w ago | Insider Cluster | $26.21 $27.74 | ▲ +5.84% | ▲ +5.30% | $25.16 (−4.01%) |
Jun 9, 2026 16w ago | 8-K | $23.23 $28.78 | ▲ +23.89% | ▲ +20.27% | $25.16 (+8.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access